Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,869 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
Davern M, Donlon NE, O'Connell F, Gaughan C, O'Donovan C, McGrath J, Sheppard AD, Hayes C, King R, Temperley H, MacLean M, Bulter C, Bhardwaj A, Moore J, Donohoe C, Ravi N, Conroy MJ, Reynolds JV, Lysaght J. Davern M, et al. Among authors: mcgrath j. J Cancer Res Clin Oncol. 2023 Jul;149(8):5377-5395. doi: 10.1007/s00432-022-04440-0. Epub 2022 Nov 29. J Cancer Res Clin Oncol. 2023. PMID: 36445478 Free PMC article.
PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma.
Davern M, O' Brien RM, McGrath J, Donlon NE, Melo AM, Buckley CE, Sheppard AD, Reynolds JV, Lynam-Lennon N, Maher SG, Lysaght J. Davern M, et al. Among authors: mcgrath j. Sci Rep. 2022 Feb 28;12(1):3259. doi: 10.1038/s41598-022-07228-x. Sci Rep. 2022. PMID: 35228614 Free PMC article.
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours.
Davern M, Fitzgerald MC, Buckley CE, Heeran AB, Donlon NE, McGrath J, O' Connell F, Deshpande MR, Hayes C, MacDonald J, Sheppard AD, Reynolds JV, Maher SG, Lynam-Lennon N, Murphy B, Lysaght J. Davern M, et al. Among authors: mcgrath j. Transl Oncol. 2022 May;19:101381. doi: 10.1016/j.tranon.2022.101381. Epub 2022 Mar 1. Transl Oncol. 2022. PMID: 35245832 Free PMC article.
A bibliometric analysis of HER2-positive breast cancer: 1987-2024.
Ali-Thompson S, Daly GR, Dowling GP, Kilkenny C, Cox L, McGrath J, AlRawashdeh MM, Naidoo S, Power C, Hill ADK. Ali-Thompson S, et al. Among authors: mcgrath j. Front Oncol. 2024 May 1;14:1355353. doi: 10.3389/fonc.2024.1355353. eCollection 2024. Front Oncol. 2024. PMID: 38769947 Free PMC article. Review.
PARP Inhibitors in Breast Cancer: a Short Communication.
Daly GR, AlRawashdeh MM, McGrath J, Dowling GP, Cox L, Naidoo S, Vareslija D, Hill ADK, Young L. Daly GR, et al. Among authors: mcgrath j. Curr Oncol Rep. 2024 Feb;26(2):103-113. doi: 10.1007/s11912-023-01488-0. Epub 2024 Jan 2. Curr Oncol Rep. 2024. PMID: 38236558 Free PMC article. Review.
2,869 results